Arkolith/Insider Trading/ARTV/Form 4

Ra Capital Management, L.P.

Director, 10% OwnerArtiva Biotherapeutics, Inc. (ARTV) · full profile →Form 4 · filed Jun 11, 2026
Net Buying
Open-Market Buys
$7.7M
Open-Market Sells
$0
Net Open-Market Flow
$7.7M
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 11, 2026Buy(P)549K$7.91$4.3M16.2M
Jun 10, 2026Buy(P)103$7.00$72115.7M
Jun 9, 2026Buy(P)479K$6.91$3.3M15.7M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001231919-26-000625) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML